Navigation Links
Protox Announces Positive Clinical Data from Prostate Cancer Study

VANCOUVER, British Columbia, July 10, 2007 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX) today announced positive top-line results from its Phase 1 clinical trial evaluating PRX302 in patients with localized, recurrent prostate cancer following radiation failure. The trial results indicate that PRX302 is safe and well tolerated and shows promising signs of therapeutic activity following a single intra-prostatic treatment.

"The completion of the PRX302 Phase 1 trial is encouraging from two perspectives," said Dr. Scott Coffield, Principal Investigator from the lead site, Scott and White Memorial Hospital. "First, there was therapeutic benefit demonstrated through overall PSA reduction in study patients, as well as a reduction in the number of positive biopsies after treatment. Second, there was no significant adverse side effect profile at the highest dose of PRX302 given to patients in this trial."

"It is heartening to see promising results at this stage of the clinical development program in a patient population which has limited therapeutic options," said Dr. Fahar Merchant, President and Chief Executive Officer of Protox. "These data support our heightened confidence regarding the potential of PRX302 for the treatment of not only prostate cancer, but also BPH, which is currently being evaluated in an ongoing Phase I trial."

This study is intended to examine the safety, tolerability and therapeutic activity of PRX302 in patients with localized recurrent prostate cancer who show signs of disease progression as evidenced by rising levels of PSA (prostate specific antigen) following radiation treatment. Using a well-established, image-guided technique, PRX302 was administered directly into the prostate. A total of 24 patients were treated in this trial. Protox has concluded that despite a 100-fold escalation in dose, the maximum tolerated dose (MTD) was not reached in this study while e
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/17/2013)... , May 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical ... Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS) ... PALS, BLS and ACLS online course manuals. ... people simply need to build an account with the ... for these programs, United Medical Education is setting a ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... 2011 HeartWare International, Inc. (NASDAQ: HTWR ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... Doug Godshall is scheduled to present at the Lazard ... 1:55 p.m. ET on Thursday, September 22, 2011.  The ...
... Laboratory Supply Company (LABSCO), the largest privately held ... hospitals, physician office laboratories, reference labs and other non-acute ... industry veteran Rod Wolford to its board ... during an incredible time of growth and opportunity, and ...
Cached Medicine Technology:HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2Rod Wolford Joins LABSCO Board of Directors 2
(Date:5/19/2013)... Chicago, IL (PRWEB) May 19, 2013 In ... Surge, LLC, E-dentist.com has announced the launch of an SEO ... help dentists get high rankings in Google. , http://www.e-dentists.com/ ... do not pay for the service until they see results. ... sites. The lead generation websites run by JD Media Surge, ...
(Date:5/19/2013)... 19, 2013 Grinding your teeth at ... sleep, or annoying your spouse. At the same time, ... Central (“Snoring and Teeth Grinding Could Be a Sign ... grinding can be hard to prevent. Apparently, Obstructive Sleep ... one of its symptoms is a habit of teeth ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock & ... published by MarketsandMarkets, defines and segments the global animal ... global volume and revenue for the animal feed additives. ... the global market with analysis of trends, opportunities, burning ... and revenue is forecasted on the basis of major ...
(Date:5/19/2013)... Farming methods have changed many times since man ... ago. Most recently, the Green Revolution has transformed farming ... seeds and by applying chemical fertilizers and pesticides. But ... due to the adverse environmental and health effects of ... interest in organic, sustainable farming practices and techniques. Enter ...
(Date:5/19/2013)... Los Angeles (PRWEB) May 19, 2013 Yeast ... infections can appear in sensitive areas of the human body. ... by Yeastrol. This new formula provides a unique method of ... This new spray solution is now provided to men and ... Yeast is naturally absorbed in the body through food and ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
... the Sheikh Zayed Institute for Pediatric Surgical Innovation ... drug that has shown early promise as an option for ... fight off bacterial infections, particularly sepsis. The study, ... Anesthesiology , sheds new light on the role of ...
... ROCHESTER, Minn. -- Global Bridges, a healthcare alliance for ... regional partner, King Hussein Cancer Center (KHCC) in Amman, ... care providers in the Eastern Mediterranean Region (EMRO) on ... training, scheduled for April 27-28 at KHCC, will engage ...
... Rice University bioengineering students in collaboration with the Texas ... chances to arrhythmia victims headed toward cardiac arrest. ... seniors created a unique pad system for automated external ... heart back into a proper rhythm in an emergency. ...
... to increase despite the use of sunscreen and ... prevent melanoma lesion formation, according to Penn State ... melanoma incidence suggests that additional preventive approaches are ... Robertson, Ph.D., professor of pharmacology, pathology, dermatology and ...
... 26, 2011) A study performed by University of ... in treating Ureaplasma-colonized or infected premature infants to prevent ... Pulmonology, showed subjects colonized or infected with the Ureaplasma ... time in the azithromycin-treated group, compared to 94 percent ...
... Reporter , MONDAY, April 25 (HealthDay News) -- The ... of life for people suffering from heart failure, Harvard ... balance and weight-shifting, breathing techniques and focused internal awareness. ... a number of medical conditions, including hypertension (high blood ...
Cached Medicine News:Health News:Study: Resiniferatoxin may increase sepsis-related mortality 2Health News:Health-care alliance for tobacco dependence treatment launches training in the Middle East 2Health News:Unique AED pads give hearts a second chance 2Health News:Topical treatment may prevent melanoma 2Health News:Antibiotic may prove beneficial to preterm infant lung health 2Health News:Tai Chi May Help Heart Failure Patients 2Health News:Tai Chi May Help Heart Failure Patients 3
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Micro emulsifying needles, 18G....
Rhoton bayonets scissors, straight tip....
Medicine Products: